Night work and breast cancer risk: A systematic review and meta-analysis

European Journal of Cancer

Volumn 41, Issue 13, 2005, Pages 2023-2032

  Megdal, Sarah P ^a   Kroenke, Candyce H ^b,c   Laden, Francine ^b,c   Pukkala, Eero ^d   Schernhammer, Eva S ^b,c,e  

^a Milken Community High School   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d FINNISH CANCER REGISTRY   (Finland)

^e LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Breast cancer; Flight attendants; Night work

Indexed keywords

BREAST CANCER; CANCER RISK; CLINICAL TRIAL; DATA BASE; HUMAN; MEDLINE; META ANALYSIS; NIGHT WORK; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

EID: 27644485423     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.05.010     Document Type: Article

References (52)

1. Pukkala E, Auvinen A, Wahlberg G. Incidence of cancer among Finnish airline cabin attendants. BMJ. 1995, 311, 649-652.
2. Rafnsson V, Tulinius H, Jonasson JG, et al. Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control 2001, 12(2), 95-101.
3. Tynes T, Hannevik M, Andersen A, et al. Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 1996, 7(2), 197-204.
4. Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology. 2001, 12(1), 74-77.
5. Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 2001, 93(20), 1557-1562.
6. Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study. J Natl Cancer Inst 2001, 93(20), 1563-1568.
7. Mawson AR. Breast cancer in female flight attendants. Lancet. 1998, 352(9128), 626.
8. Whelan EA. Cancer incidence in airline cabin crew. Occup Environ Med 2003, 60(11), 805-806.
9. Ballard T, Lagorio S, De Angelis G, et al. Cancer incidence and mortality among flight personnel: a meta-analysis. Aviat Space Environ Med 2000, 71(3), 216-224.
10. Rafnsson V, Sulem P, Tulinius H, et al. Breast cancer risk in airline cabin attendants: a nested case-control study in Iceland. Occup Environ Med 2003, 60(11), 807-809.
11. Auvinen A, Karjalainen S, Pukkala E. Social class and cancer patient survival in Finland. Am J Epidemiol 1995, 142, 1089-1102.
12. Rafnsson V, Gunnarsdottir H. Mortality study of fertiliser manufacturers in Iceland. Br J Ind Med 1990, 47(11), 721-725.
13. Taylor PJ, Pocock SJ. Mortality of shift and day workers 1956-68. Br J Ind Med 1972, 29(2), 201-207.
14. Pfeiffer CJ, Fodor JG, Canning E. An epidemiologic analysis of mortality and gastric cancer in Newfoundland. Can Med Assoc J 1973, 108(11), 1374-1380.
15. Schernhammer E, Kroenke C, Laden F, et al. Night work and melatonin levels in women participating in the Nurses' Health Study II: associate with breast cancer risk. In: 2nd symposium of the Dana-Farber/Harvard cancer center program in breast cancer 2005. Boston; 2005.
16. Lie J-AS, Roessink J, Kjaerheim K. Breast cancer and night work among Norwegian nurses. Cancer Causes Control in press.
17. Reynolds P, Cone J, Layefsky M, et al. Cancer incidence in California flight attendants (United States). Cancer Causes Control 2002, 13(4), 317-324.
18. Wartenberg D, Stapleton CP. Risk of breast cancer is also increased among retired US female airline cabin attendants. Br Med J 1998, 316(7148), 1902.
19. STATA commands for meta-analyses. STATA vol. 1. In: College Station, Tex.; 2001.
20. Haldorsen T, Reitan JB, Tveten U. Cancer incidence among Norwegian airline cabin attendants. Int J Epidemiol 2001, 30(4), 825-830.
21. Linnersjö A, Hammar N, Dammstrom BG, et al. Cancer incidence in airline cabin crew: experience from Sweden. Occup Environ Med 2003, 60(11), 810-814.
22. Walker AM. Observation and inference: an introduction to the methods of epidemiology. Newton Lower Falls, Epidemiology Resources Inc., 1991.
23. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7, 177-188.
24. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50(4), 1088-1101.
25. Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315(7109), 629-634.
26. Tang JL, Liu JL. Misleading funnel plot for detection of bias in meta-analysis. J Clin Epidemiol 2000, 53(5), 477-484.
27. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001, 54(10), 1046-1055.
28. Lynge E. Risk of breast cancer is also increased among Danish female airline cabin attendants. Br Med J 1996, 312(7025), 253.
29. Kerenyi NA, Pandula E, Feuer GM. Oncostatic effects of the pineal gland. Drug Metab Drug Interact 1990, 8(3-4), 313-319.
30. Stevens RG, Davis S. The melatonin hypothesis: electric power and breast cancer. Environ Health Perspect 1996, 104, 135-140.
31. Hill SM, Blask DE. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 1988, 48(21), 6121-6126.
32. Cos S, Fernandez F, Sanchez-Barcelo EJ. Melatonin inhibits DNA synthesis in MCF-7 human breast cancer cells in vitro. Life Sci 1996, 58(26), 2447-2453.
33. Cos S, Fernandez R, Guezmes A, et al. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res 1998, 58, 4383-4390.
34. Mediavilla MD, Cos S, Sanchez-Barcelo EJ. Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life Sci 1999, 65(4), 415-420.
35. Cos S, Mediavilla MD, Fernandez R, et al. Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro? J Pineal Res 2002, 32(2), 90-96.
36. Ying SW, Niles LP, Crocker C. Human malignant melanoma cells express high-affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin. Eur J Pharmacol 1993, 246(2), 89-96.
37. Sze SF, Ng TB, Liu WK. Antiproliferative effect of pineal indoles on cultured tumour cell lines. J Pineal Res 1993, 14(1), 27-33.
38. Shiu SY, Li L, Xu JN, et al. Melatonin-induced inhibition of proliferation and G1/S cell cycle transition delay of human choriocarcinoma JAr cells: possible involvement of MT2 (MEL1B) receptor. Pineal Res 1999, 27(3), 183-192.
39. Petranka J, Baldwin WS, Bierman J, et al. The oncostatic action of melatonin in an ovarian carcinoma cell line. Pineal Res 1999, 26, 129-136.
40. Kanishi Y, Kobayashi Y, Noda S, et al. Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines. J Pineal Res 2000, 28(4), 227-233.
41. Tamarkin L, Cohen M, Roselle D, et al. Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumours in the rat. Cancer Res 1981, 41(11 Pt 1), 4432-4436.
42. Musatov SA, Anisimov VN, Andre V, et al. Effects of melatonin on N-nitroso-N-methylurea-induced carcinogenesis in rats and mutagenesis in vitro (Ames test and COMET assay). Cancer Lett 1999, 138, 37-44.
43. Cini G, Coronnello M, Mini E, et al. Melatonin's growth-inhibitory effect on hepatoma AH 130 in the rat. Cancer Lett 1998. 125(1-2), 51-59.
44. Mocchegiani E, Perissin L, Santarelli L, et al. Melatonin administration in tumour-bearing mice (intact and pinealectomized) in relation to stress, zinc, thymulin and IL-2. Int J Immunopharmacol 1999. 21(1), 27-46.
45. Anisimov VN, Popovich IG, Zabezhinski MA. Melatonin and colon carcinogenesis: I. Inhibitory effect of melatonin on development of intestinal tumours induced by 1,2-dimethylhydrazine in rats. Carcinogenesis 1997, 18, 1549-1553.
46. Anisimov VN, Kvetnoy IM, Chumakova NK, et al. Melatonin and colon carcinogenesis. Exp Toxicol Pathol 1999, 51, 47-52.
47. Brzezinski A. Melatonin in humans. N Engl J Med 1997, 336(3), 186-195.
48. Antunes F, Barclay LR, Ingold KU, et al. On the antioxidant activity of melatonin. Free Radic Biol Med 1999, 26(1-2), 117-128.
49. Blask DE, Sauer LA, Dauchy RT, et al. Melatonin inhibition of cancer growth in vivo involves supression of tumour fatty acid metabolism via melatonin receptor-mediated signal. Cancer Res 1999, 59,4693-4701.
50. Vijayalaxmi, Thomas CRJ, Reiter RJ, Herman TS, et al. Melatonin: from basic research to cancer treatment clinics. J Clin Oncol 2002. 20(10), 2575-2601.
51. Zeeb H, Blettner M, Langner I, et al. Mortality from cancer and other causes among airline cabin attendants in Europe: a collaborative cohort study in eight countries. Am J Epidemiol 2003. 158(1), 35-46.
52. Karjalainen S, Pukkala E. Social class as a prognostic factor in breast cancer survival. Cancer 1990, 66(4), 819-826.